Literature DB >> 26758864

Rapid Aspirin Challenge in Patients with Aspirin Allergy and Acute Coronary Syndromes.

Kevin A Cook1, Andrew A White2.   

Abstract

Aspirin allergy in a patient with acute coronary syndrome represents one of the more urgent challenges an allergist may face. Adverse reactions to aspirin are reported in 1.5% of patients with coronary artery disease. A history of adverse reaction to aspirin often leads to unnecessary withholding of this medication or use of alternative antiplatelet therapy which may be inferior or more costly. Aspirin therapy has been shown to reduce morbidity and mortality in patients with coronary artery disease. Rapid aspirin challenge/desensitization in the aspirin allergic patient has been consistently shown to be both safe and successful in patients with acute coronary syndromes.

Entities:  

Keywords:  Acute coronary syndrome; Aspirin allergy; Aspirin benefit; Aspirin challenge; Aspirin desensitization; Aspirin reaction; Aspirin therapy; Coronary artery disease

Mesh:

Substances:

Year:  2016        PMID: 26758864     DOI: 10.1007/s11882-015-0593-2

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  30 in total

Review 1.  Aspirin sensitivity: implications for patients with coronary artery disease.

Authors:  Raghava R Gollapudi; Paul S Teirstein; Donald D Stevenson; Ronald A Simon
Journal:  JAMA       Date:  2004-12-22       Impact factor: 56.272

2.  Rapid desensitization to acetylsalicylic acid in acute coronary syndrome patients with NSAID intolerance.

Authors:  Gaspar Dalmau; Pere Gaig; Vanessa Gázquez; Jordi Mercé
Journal:  Rev Esp Cardiol       Date:  2009-02       Impact factor: 4.753

3.  2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Alice K Jacobs
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

Review 4.  Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs.

Authors:  M L Kowalski; R Asero; S Bavbek; M Blanca; N Blanca-Lopez; G Bochenek; K Brockow; P Campo; G Celik; J Cernadas; G Cortellini; E Gomes; E Niżankowska-Mogilnicka; A Romano; A Szczeklik; S Testi; M J Torres; S Wöhrl; J Makowska
Journal:  Allergy       Date:  2013-10-05       Impact factor: 13.146

5.  Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease.

Authors:  Kathryn L McMullan; H James Wedner
Journal:  Clin Cardiol       Date:  2012-09-18       Impact factor: 2.882

Review 6.  Aspirin desensitization for cardiovascular disease.

Authors:  Katharine M Woessner
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-08

7.  Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.

Authors:  Stéphane Silberman; Catherine Neukirch-Stoop; Philippe Gabriel Steg
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

8.  Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach.

Authors:  G Cortellini; S Testi; M Severino; T Chechi; M L Iorno; A Santucci; A Corvetta; G Piovaccari; A Santarelli; N Franco; G W Canonica; G Passalacqua
Journal:  Eur Ann Allergy Clin Immunol       Date:  2012-08

9.  Drug-induced angioedema without urticaria: prevalence and clinical features.

Authors:  C Leeyaphan; K Kulthanan; K Jongjarearnprasert; N Dhana
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-11-17       Impact factor: 6.166

10.  Characterization of aspirin allergies in patients with coronary artery disease.

Authors:  Charles H Feng; Andrew A White; Donald D Stevenson
Journal:  Ann Allergy Asthma Immunol       Date:  2013-02       Impact factor: 6.347

View more
  3 in total

1.  The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.

Authors:  Ying Xue; Zhi-Wei Feng; Xiao-Ye Li; Zi-Heng Hu; Qing Xu; Zi Wang; Jia-Hui Cheng; Hong-Tao Shi; Qi-Bing Wang; Hong-Yi Wu; Xiang-Qun Xie; Qian-Zhou Lv
Journal:  Acta Pharmacol Sin       Date:  2017-09-21       Impact factor: 6.150

2.  Cilostazol combined with P2Y12 receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantation.

Authors:  Yikai Zhao; Peng Zhou; Wen Gao; Haoxuan Zhong; Yufei Chen; Wei Chen; Maieryemu Waresi; Kun Xie; Haiming Shi; Hui Gong; Guibin He; Zhaohui Qiu; Xinping Luo; Jian Li
Journal:  Clin Cardiol       Date:  2022-02-04       Impact factor: 2.882

Review 3.  Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management.

Authors:  Ravi A Thakker; Leonardo Salazar; Deaa Abu Jazar; Pooja Bhakta; Bryan Baker; Chandani Patel; Ayman Elbadawi; Mayank Agarwal; Aiham Albaeni; Mohammed Saleh; Jonathan Esclovan; Danielle El Haddad; Hashim Alwash; Ankur Kalra; Sachin S Goel; Robert Jay Widmer; Khaled Chatila; Wissam Khalife; Afaq Motiwala; Jennifer McCracken; Hani Jneid; Syed Gilani
Journal:  Cardiol Ther       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.